Pharma 2023: Nuevas drogas que se lanzarán y aprobarán desde Agosto 2023 en Adelante. Sus proyecciones.
- netmd
- 13 de agosto de 2023
- Pharma Industry
- 0 Comments
Las Drogas que se lanzarán en 2023 desde Agosto en Adelante.
Descargue el Excel aqui:
| COMPANY | COUNTRY | CURRENCY | MARKET CAP (Bn) | CHANGE IN MARKET CAP (M) | STOCK PRICE | CHANGE IN PRICE |
| PeptiDream (4587.T) | Japan | JPY | 234,48 | -45.570 | 1.833 | -16,1% |
| Merck & Co (MRK) | U.S.A | USD | 267,88 | -20.320 | 107 | -7,0% |
| Apellis Pharmaceuticals (APLS) | U.S.A | USD | 4,01 | -6.871 | 32 | -64,8% |
| Eli Lilly (LLY) | U.S.A | USD | 426,66 | -6.645 | 459 | -1,5% |
| Bristol Myers Squibb (BMY) | U.S.A | USD | 130,13 | -6.300 | 62 | -4,6% |
| Pfizer Inc (PFE) | U.S.A | USD | 202,44 | -5.650 | 36 | -2,7% |
| Takeda Pharmaceutical (TAK) | Japan | USD | 48,11 | -3.110 | 15 | -6,3% |
| Biogen (BIIB) | U.S.A | USD | 40,37 | -1.882 | 273 | -4,5% |
| Moderna Therapeutics (MRNA) | U.S.A | USD | 46,74 | -1.525 | 119 | -3,3% |
| Vir Biotechnology (VIR) | U.S.A | USD | 3,09 | -1.474 | 14 | -44,0% |
| NovoCure (NVCR) | U.S.A | USD | 3,54 | -850 | 35 | -18,6% |
| Horizon Therapeutics (HZNP) | Ireland | USD | 23,16 | -686 | 100 | -2,9% |
| TG Therapeutics (TGTX) | U.S.A | USD | 3,21 | -598 | 21 | -16,0% |
| Sarepta Therapeutics (SRPT) | U.S.A | USD | 9,84 | -466 | 109 | -4,4% |
| Mirati Therapeutics (MRTX) | U.S.A | USD | 2,01 | -466 | 31 | -20,5% |
| Madrigal Pharmaceuticals (MDGL) | U.S.A | USD | 3,95 | -439 | 208 | -10,3% |
| Mersana Therapeutics (MRSN) | U.S.A | USD | 0,14 | -343 | 1 | -75,0% |
| Alkermes Plc (ALKS) | Ireland | USD | 4,78 | -332 | 29 | -6,5% |
| Theseus Pharmaceuticals (THRX) | U.S.A | USD | 0,13 | -305 | 3 | -70,0% |
| Biohaven Pharmaceuticals (BHVN) | U.S.A | USD | 1,62 | -273 | 20 | -16,7% |
| Akero Therapeutics (AKRO) | U.S.A | USD | 2,52 | -221 | 43 | -8,5% |
| Seagen (SGEN) | U.S.A | USD | 37,05 | -188 | 193 | -0,5% |
| Vaxcyte (PCVX) | U.S.A | USD | 4,55 | -187 | 48 | -4,0% |
| Pacira BioSciences (PCRX) | U.S.A | USD | 1,74 | -184 | 36 | -10,0% |
| Stoke Therapeutics (STOK) | U.S.A | USD | 0,29 | -177 | 7 | -36,4% |
| Ventyx Biosciences (VTYX) | U.S.A | USD | 2,08 | -176 | 38 | -7,3% |
| Replimune (REPL) | U.S.A | USD | 1,20 | -173 | 21 | -12,5% |
| Ambrx Inc (AMAM) | U.S.A | USD | 0,89 | -121 | 15 | -11,8% |
| Cytokinetics (CYTK) | U.S.A | USD | 3,34 | -96 | 33 | -2,9% |
| Mineralys Therapeutics (MLYS) | U.S.A | USD | 0,63 | -82 | 15 | -11,8% |
| Vigil Neuroscience (VIGL) | U.S.A | USD | 0,26 | -71 | 8 | -20,0% |
| AEON Biopharma (AEON) | U.S.A | USD | 0,16 | -64 | 9 | -25,0% |
| Emergent BioSolutions (EBS) | U.S.A | USD | 0,40 | -50 | 7 | -12,5% |
| VBI Vaccines (VBIV) | U.S.A | USD | 0,03 | -46 | 1 | -66,7% |
| Icosavax (ICVX) | U.S.A | USD | 0,39 | -41 | 9 | -10,0% |
| Apogee Therapeutics (APGE) | U.S.A | USD | 0,99 | -34 | 21 | -4,5% |
| Bicycle Therapeutics (BCYC) | United Kingdom | USD | 0,79 | -30 | 25 | -3,8% |
| Tonix Pharmaceuticals Holding Corp (TNXP) | U.S.A | USD | 0,01 | -10 | 1 | -50,0% |
| ADC Therapeutics (ADCT) | Switzerland | USD | 0,12 | 0 | 2 | 0,0% |
| Astellas Pharma (ALPMY) | Japan | USD | 26,53 | 0 | 15 | 0,0% |
| Beam Therapeutics (BEAM) | U.S.A | USD | 2,35 | 0 | 32 | 0,0% |
| Biomea Fusion (BMEA) | U.S.A | USD | 0,81 | 0 | 22 | 0,0% |
| Catalyst Pharmaceuticals (CPRX) | U.S.A | USD | 1,44 | 0 | 14 | 0,0% |
| Generation Bio (GBIO) | U.S.A | USD | 0,33 | 0 | 5 | 0,0% |
| Gilead Sciences (GILD) | U.S.A | USD | 96,28 | 0 | 77 | 0,0% |
| Gossamer Bio (GOSS) | U.S.A | USD | 0,12 | 0 | 1 | 0,0% |
| GSK (GSK) | United Kingdom | USD | 70,78 | 0 | 36 | 0,0% |
| Hansoh Pharma (3692.HK) | China | HKD | 75,24 | 0 | 13 | 0,0% |
| Intra-Cellular Therapies (ITCI) | U.S.A | USD | 6,09 | 0 | 63 | 0,0% |
| Ionis Pharmaceuticals (IONS) | U.S.A | USD | 5,69 | 0 | 42 | 0,0% |
| Mirum Pharmaceuticals (MIRM) | U.S.A | USD | 0,96 | 0 | 26 | 0,0% |
| Paratek Pharmaceuticals (PRTK) | U.S.A | USD | 0,12 | 0 | 2 | 0,0% |
| Poseida Therapeutics, Inc (PSTX) | U.S.A | USD | 0,16 | 0 | 2 | 0,0% |
| Prothena (PRTA) | Ireland | USD | 3,38 | 0 | 69 | 0,0% |
| PTC Therapeutics (PTCT) | U.S.A | USD | 3,04 | 0 | 42 | 0,0% |
| Sangamo Therapeutics (SGMO) | U.S.A | USD | 0,23 | 0 | 1 | 0,0% |
| Sanofi (SNY) | France | USD | 132,25 | 0 | 54 | 0,0% |
| Santhera Pharmaceuticals (SANN.SW) | Switzerland | CHF | 0,10 | 0 | 9 | 0,0% |
| Silence Therapeutics (SLNCF) | United Kingdom | USD | 0,09 | 0 | 1 | 0,0% |
| Synaptogenix (SNPX) | U.S.A | USD | 0,01 | 0 | 1 | 0,0% |
| Cabaletta Bio (CABA) | U.S.A | USD | 0,60 | 40 | 14 | 7,7% |
| 4D Molecular Therapeutics (FDMT) | U.S.A | USD | 0,75 | 42 | 19 | 5,6% |
| Crinetics Pharmaceuticals (CRNX) | U.S.A | USD | 1,01 | 54 | 19 | 5,6% |
| Phathom Pharmaceuticals (PHAT) | U.S.A | USD | 0,80 | 56 | 16 | 6,7% |
| Novavax (NVAX) | U.S.A | USD | 0,70 | 86 | 9 | 12,5% |
| Amphastar Pharmaceuticals (AMPH) | U.S.A | USD | 2,70 | 97 | 61 | 3,4% |
| Nanobiotix (NBTX) | France | USD | 0,32 | 105 | 8 | 60,0% |
| Castle Biosciences (CSTL) | U.S.A | USD | 0,43 | 107 | 18 | 28,6% |
| Acumen Pharmaceuticals (ABOS) | U.S.A | USD | 0,26 | 123 | 8 | 60,0% |
| Travere Therapeutics (TVTX) | U.S.A | USD | 1,18 | 149 | 18 | 12,5% |
| Evelo Biosciences (EVLO) | U.S.A | USD | 0,22 | 150 | 11 | 266,7% |
| Tarsus Pharmaceuticals (TARS) | U.S.A | USD | 0,66 | 161 | 24 | 33,3% |
| Kiniksa Pharmaceuticals (KNSA) | U.S.A | USD | 1,36 | 175 | 19 | 35,7% |
| BioMarin Pharmaceutical (BMRN) | U.S.A | USD | 16,12 | 188 | 88 | 1,1% |
| Centessa Pharmaceuticals (CNTA) | U.S.A | USD | 0,76 | 191 | 8 | 33,3% |
| BioNTech (BNTX) | Germany | USD | 26,09 | 241 | 110 | 0,9% |
| Blueprint Medicines (BPMC) | U.S.A | USD | 3,48 | 242 | 68 | 6,3% |
| Neuren Pharmaceuticals (NEU.AX) | Australia | AUD | 1,77 | 258 | 14 | 16,7% |
| Caribou Biosciences (CRBU) | U.S.A | USD | 0,42 | 264 | 8 | 100,0% |
| UroGen Pharma (URGN) | U.S.A | USD | 0,53 | 281 | 22 | 120,0% |
| SpringWorks Therapeutics (SWTX) | U.S.A | USD | 1,87 | 313 | 32 | 18,5% |
| Bio-Techne (TECH) | U.S.A | USD | 14,08 | 315 | 84 | 2,4% |
| Immunocore (IMCR) | United Kingdom | USD | 2,93 | 370 | 67 | 13,6% |
| Jazz Pharmaceuticals (JAZZ) | Ireland | USD | 8,09 | 385 | 131 | 4,8% |
| Nuvalent (NUVL) | U.S.A | USD | 2,45 | 411 | 50 | 19,0% |
| Immunovant (IMVT) | U.S.A | USD | 3,13 | 522 | 23 | 21,1% |
| Evotec (EVO) | Germany | USD | 4,74 | 708 | 13 | 18,2% |
| Neurocrine Biosciences (NBIX) | U.S.A | USD | 9,37 | 878 | 104 | 9,5% |
| Halozyme Therapeutics (HALO) | U.S.A | USD | 5,03 | 922 | 44 | 18,9% |
| United Therapeutics (UTHR) | U.S.A | USD | 10,98 | 937 | 245 | 8,9% |
| Acadia Pharmaceuticals (ACAD) | U.S.A | USD | 5,23 | 976 | 30 | 25,0% |
| Recursion Pharma (RXRX) | U.S.A | USD | 2,58 | 1.108 | 14 | 75,0% |
| Alnylam Pharmaceuticals (ALNY) | U.S.A | USD | 24,54 | 1.245 | 200 | 5,3% |
| Legend Biotech (LEGN) | U.S.A | USD | 12,63 | 1.262 | 76 | 10,1% |
| Vertex Pharmaceuticals (VRTX) | U.S.A | USD | 92,20 | 1.288 | 354 | 1,4% |
| Roivant Sciences (ROIV) | U.S.A | USD | 8,94 | 1.534 | 12 | 20,0% |
| Reata Pharmaceuticals (RETA) | U.S.A | USD | 6,24 | 2.082 | 167 | 60,6% |
| Regeneron Pharmaceuticals (REGN) | U.S.A | USD | 79,17 | 2.481 | 745 | 3,2% |
| Genmab (GMAB) | Denmark | USD | 26,12 | 2.611 | 42 | 10,5% |
| BridgeBio Pharma (BBIO) | U.S.A | USD | 5,48 | 2.889 | 36 | 100,0% |
| Bayer AG (BAYN.DE) | Germany | EUR | 49,34 | 2.947 | 54 | 5,9% |
| BeiGene (BGNE) | China | USD | 20,78 | 4.113 | 221 | 21,4% |
| Novo Nordisk (NVO) | Denmark | USD | 360,66 | 4.480 | 162 | 1,3% |
| Amgen Inc (AMGN) | U.S.A | USD | 121,52 | 5.343 | 236 | 4,4% |
| F. Hoffmann-La Roche (RHHBY) | Switzerland | USD | 254,53 | 6.390 | 39 | 2,6% |
| argenx (ARGX) | Netherlands | USD | 21,21 | 6.883 | 511 | 31,7% |
| Novartis Pharmaceuticals Corporation (NVS) | Switzerland | USD | 209,71 | 10.600 | 105 | 5,0% |
| AstraZeneca (AZN) | United Kingdom | USD | 208,86 | 15.500 | 72 | 7,5% |
| Johnson & Johnson (JNJ) | U.S.A | USD | 413,38 | 15.600 | 170 | 3,7% |
| AbbVie Inc (ABBV) | U.S.A | USD | 239,96 | 28.160 | 151 | 11,9% |
| Otsuka Holdings (4578.T) | Japan | JPY | 2.815,00 | 104.728 | 5.507 | 3,6% |
